Today, iCoat Medical welcomes Mattias Springare as its incoming Chief Financial Officer and Head of Investor Relations!
iCoat Medical has an ambitious CFO-agenda during 2022 including expanding our finance- and accounting functions, transition the company into an IFRS-standard and commence the early preparation for a potential IPO in late 2022, as previously communicated. Also, the company will gradually develop its Investor Relations-function to meet the requirements connected with a potential IPO and serve the growing number of shareholders in iCoat Medical.
“Mattias has extensive experience both as CFO, Head of Finance and Auditor and is used to working in rapidly expanding businesses with a high rate of change. I am happy to welcome him as a member of iCoat Medical’s management team and look forward to working with him in the future” says iCoat Medical’s CEO Peder Waern.
Mattias most recently comes from the role as CFO at Taxi Stockholm and has previously held senior positions at FASAB 6F, Brightstep (part of Accenture) and IKG Group as well as serving as an accountant at KPMG.
Mattias holds a M.Sc. in accounting and auditing.
For more information, please contact:
Peder Waern, CEO, iCoat Medical AB